Endogenous Brucella endophthalmitis: A case report
dc.contributor.author | Oray, Merih | |
dc.contributor.author | Cebeci, Zafer | |
dc.contributor.author | Kir, Nur | |
dc.contributor.author | Ozturk, Banu Turgut | |
dc.contributor.author | Oksuz, Lutfiye | |
dc.contributor.author | Tugal-Tutkun, Ilknur | |
dc.date.accessioned | 2020-03-26T19:41:42Z | |
dc.date.available | 2020-03-26T19:41:42Z | |
dc.date.issued | 2017 | |
dc.department | Selçuk Üniversitesi | en_US |
dc.description.abstract | Brucellosis may be associated with a wide range of ophthalmic manifestations including endophthalmitis, which is a sightthreatening condition that needs to be rapidly recognized and treated to avoid permanent visual loss. A 26-year-old female with a 6-month history of vision loss in the left eye was treated with high dose systemic corticosteroids and azathioprine with an initial misdiagnosis elsewhere. A dense vitreous haze with opacities at the posterior hyaloid and a wide area of retinochoroiditis led to the diagnosis of endogenous endophthalmitis at presentation to us. The vitreous sample and blood cultures demonstrated growth of Brucella melitensis. She received 6 months of systemic antibiotherapy, which resulted in resolution of inflammation; however, visual acuity remained poor due to irreversible damage. Infectious etiology, including brucellosis in endemic countries, has to be considered in the differential diagnosis before administering immunomodulatory therapy in patients with panuveitis of unknown origin. | en_US |
dc.description.sponsorship | AllerganAllergan | en_US |
dc.description.sponsorship | None of the authors has any financial or proprietary interest in any material or method mentioned in this paper. Ilknur Tugal-Tutkun has received financial support outside the submitted work, including honoraria from Servier and AbbVie and lecture fees from Allergan. No government or nongovernment funding support has been obtained. | en_US |
dc.identifier.doi | 10.1016/j.sjopt.2017.03.002 | en_US |
dc.identifier.endpage | 108 | en_US |
dc.identifier.issn | 1319-4534 | en_US |
dc.identifier.issue | 2 | en_US |
dc.identifier.pmid | 28559723 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 106 | en_US |
dc.identifier.uri | https://dx.doi.org/10.1016/j.sjopt.2017.03.002 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12395/35070 | |
dc.identifier.volume | 31 | en_US |
dc.identifier.wos | WOS:000406188800010 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | ELSEVIER SCIENCE BV | en_US |
dc.relation.ispartof | SAUDI JOURNAL OF OPHTHALMOLOGY | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.selcuk | 20240510_oaig | en_US |
dc.subject | Endogenous endophthalmitis | en_US |
dc.subject | Ocular brucellosis | en_US |
dc.subject | Panuveitis | en_US |
dc.title | Endogenous Brucella endophthalmitis: A case report | en_US |
dc.type | Article | en_US |